RTI Biologics, Inc. · Alachua, FL United States (NASDAQ: RTIX)
Key RTI Biologics, Inc. Financials
| Company Type | Public -(NASDAQ: RTIX) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2001 Sales (mil.) | $140.7 |
| 2010 Employees | 711 |
RTI Biologics, Inc. Income Statement
| Dec 01 | Dec 00 | Dec 99 | |
| Revenue | 140.7 | 122.5 | 33.0 |
| Cost of Goods Sold | 112.6 | 91.3 | 18.6 |
| Gross Profit | 28.1 | 31.2 | 14.4 |
| Gross Profit Margin | 20% | 25.5% | 43.7% |
| SG&A Expense | 36.0 | 20.6 | 9.7 |
| Depreciation & Amortization | 2.3 | 1.4 | 0.6 |
| Operating Income | (10.5) | 6.8 | -- |
| Operating Margin | -7.5% | 5.6% | --% |
| Nonoperating Income | 1.2 | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (9.3) | -- | -- |
| Income Taxes | (3.8) | 3.1 | (0.6) |
| Net Income After Taxes | (5.5) | (3.1) | 0.6 |
| Continuing Operations | (5.5) | 4.5 | 3.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (5.5) | 4.5 | 3.0 |
| Total Net Income | (5.5) | 4.5 | 3.0 |
| Net Profit Margin | -3.9% | 3.6% | 9% |
| Diluted EPS from Total Net Income | (0.25) | 0.22 | 0.18 |
| Dividends per Share | -- | -- | 0.0 |
All amounts in millions of US Dollars except per share amounts.
RTI Biologics, Inc. Balance Sheet
| Assets | Dec 01 | Dec 00 | Dec 99 |
| Current Assets | |||
| Cash | 13.5 | 34.9 | 7.5 |
| Net Receivables | 21.7 | 27.6 | 15.5 |
| Inventories | 29.3 | 23.4 | 16.2 |
| Other Current Assets | 8.9 | 3.4 | 1.9 |
| Total Current Assets | 73.4 | 89.4 | 41.2 |
| Net Fixed Assets | 36.1 | 14.8 | 5.8 |
| Other Noncurrent Assets | 9.2 | 4.7 | 1.5 |
| Total Assets | 118.7 | 108.9 | 48.5 |
| Liabilities | Dec 01 | Dec 00 | Dec 99 |
| Current Liabilities | |||
| Accounts Payable | 22.0 | 22.4 | 21.1 |
| Short-Term Debt | 16.0 | 1.2 | -- |
| Other Current Liabilities | 7.7 | 5.4 | 6.1 |
| Total Current Liabilities | 45.7 | 29.0 | 27.1 |
| Long-Term Debt | 0.7 | 3.7 | -- |
| Other Noncurrent Liabilities | 4.5 | 3.7 | 6.0 |
| Total Liabilities | 50.9 | 36.4 | 33.1 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 67.8 | 72.5 | 15.4 |
| Total Equity | 67.8 | 72.5 | 15.4 |
| Shares Outstanding (thou.) | 21,843.2 | 54,806.8 | 54,550.4 |
All amounts in millions of US Dollars except per share amounts.
RTI Biologics, Inc. Cash Flow Statement
| Dec 01 | Dec 00 | Dec 99 | |
| Net Operating Cash Flow | (4) | (9) | (6) |
| Net Investing Cash Flow | (28.4) | (10.3) | (2.9) |
| Net Financing Cash Flow | 11.4 | 47.0 | 13.0 |
| Net Change in Cash | (21.4) | 27.4 | 3.6 |
| Depreciation & Amortization | 2.3 | 1.4 | 0.6 |
| Capital Expenditures | (23.2) | (10.1) | (2.9) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.